NewLink Genetics (NLNK) Tops Q1 EPS by 6c

NewLink Genetics (NASDAQ: NLNK) reported Q1 EPS of ($0.49), $0.06 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $0 versus the consensus estimate of $4.73 million.

For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance